Operating Segments

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Operating Segments

Note 11. Operating Segments

The Company maintains two active operating segments: Specialized BioTherapeutics and Public Health Solutions. Each segment includes an element of overhead costs specifically associated with its operations, with its corporate shared services group responsible for support functions generic to both operating segments.

	For the Years Ended December 31,
	2019			2018
Revenues
Public Health Solutions	$	3,402,014		$	4,156,641
Specialized BioTherapeutics		1,227,902			1,084,807
Total	$	4,629,916		$	5,241,448
Income (Loss) from Operations
Public Health Solutions	$	153,969		$	(237,640	)
Specialized BioTherapeutics		(6,738,284	)		(5,439,294	)
Corporate		(3,956,706	)		(3,382,047	)
Total	$	(10,541,021	)	$	(9,058,981	)
Amortization and Depreciation Expense
Public Health Solutions	$	17,507		$	17,951
Specialized BioTherapeutics		18,122			21,018
Corporate		18,821			5,091
Total	$	54,450		$	44,060
Other Income, Net
Specialized BioTherapeutics	$	425,785			-
Corporate		148,968			159,006
Total	$	574,753		$	159,006
Share-Based Compensation
Public Health Solutions	$	36,003		$	57,307
Specialized BioTherapeutics		107,214			117,570
Corporate		233,122			206,009
Total	$	376,339		$	380,886

	As of December 31,
	2019		2018
Identifiable Assets
Public Health Solutions	$	1,018,673	$	1,181,114
Specialized BioTherapeutics		41,705		78,336
Corporate		6,714,983		9,232,252
Total	$	7,775,360	$	10,491,702